Signal-peptide-peptidase-like 2a (SPPL2a) is targeted to lysosomes/late endosomes by a tyrosine motif in its C-terminal tail  by Behnke, Jörg et al.
FEBS Letters 585 (2011) 2951–2957journal homepage: www.FEBSLetters .orgSignal-peptide-peptidase-like 2a (SPPL2a) is targeted to lysosomes/late
endosomes by a tyrosine motif in its C-terminal tail
Jörg Behnke a, Janna Schneppenheim a, Friedrich Koch-Nolte b, Friedrich Haag b, Paul Saftig a,
Bernd Schröder a,⇑
aBiochemical Institute, Christian-Albrechts-University Kiel, Olshausenstrasse 40, D-24118 Kiel, Germany
b Institute of Immunology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany
a r t i c l e i n f o a b s t r a c tArticle history:
Received 11 May 2011
Revised 29 August 2011
Accepted 29 August 2011
Available online 2 September 2011






Tyrosine-based sorting motif0014-5793/$36.00  2011 Federation of European Bio
doi:10.1016/j.febslet.2011.08.043
Abbreviations: RIP, regulated intramembrane pro
peptidase; SPPL, signal-peptide-peptidase-like; FasL
necrosis factor a; BMP, bis(monoacylglycero)phosphat
phosphate-dehygrogenase; MEF, murine embryonic ﬁ
⇑ Corresponding author. Address: Biochemical In
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E-mail address: baschroeder@biochem.uni-kiel.deSignal-peptide-peptidase-like 2A (SPPL2a), an aspartyl intramembrane protease, has been impli-
cated in the proteolysis of TNF-alpha, Fas Ligand and Bri2. Here, we show that endogenous SPPL2a
– in agreement with overexpression studies – is localised in membranes of lysosomes/late endo-
somes. Furthermore, we have analysed the molecular determinants for lysosomal sorting of SPPL2a
by creating chimaeric constructs between SPPL2a and its plasma membrane localised homologue
SPPL2b. Lysosomal transport of SPPL2a critically depends on its cytosolic carboxyterminal tail. A
canonical tyrosine-based sorting motif of the YXXø type at position 498 is sufﬁcient to direct SPPL2a
to lysosomal/late endosomal compartments. This motif accounts for the differential localisation of
the homologous proteases SPPL2a and SPPL2b and thereby inﬂuences the access to substrates and
biological function of SPPL2a.
Structured summary of protein interactions:
LAMP2 and SPPL2a colocalize by ﬂuorescence microscopy (view interaction)
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Regulated intramembrane proteolysis (RIP) refers to a two-step
proteolytic cascade comprising the ectodomain release from a
transmembrane substrate followed by an intramembrane cleavage
and liberation of an intracellular domain [1]. RIP has emerged over
the last years as an important principle in cellular signaling [1,2].
Signal-peptide-peptidase (SPP) and its homologues Signal-
peptide-peptidase-like (SPPL) 2a, -2b, -2c, and -3 belong to the
class of aspartyl intramembrane-cleaving proteases (I-CliPs). They
show a substrate preference towards type 2 transmembrane
proteins [2]. Within the SPP/SPPL family, a functional relationship
between SPPL2a and SPPL2b was suggested [3].
SPPL2a and/or SPPL2b have been implicated in the intramem-
brane cleavage of TNF-a [3], Bri2 [4] and Fas ligand [5]. SPPL2achemical Societies. Published by E
teolysis; SPP, signal-peptide-
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(B. Schröder).and -b are 50% identical and 70% homologous to each other [2].
In mRNA analyses, SPPL2a was found to be expressed in all major
human adult tissues, whereas SPPL2b transcripts were primarily
detected in the adrenal cortex and the mammary gland [6].
SPPL2a and SPPL2b exhibit distinct subcellular localisations.
Overexpressed SPPL2a was observed in late endosomal compart-
ments colocalising with Rab-7 [3]. In agreement, endogenous
SPPL2a was found to be enriched in lysosomal membranes isolated
from human placenta in an organellar proteomic study [7]. In con-
trast, overexpressed SPPL2b has been detected at the plasma mem-
brane [3].
It seems likely that the divergent subcellular localization in
addition to the distinct tissue expression pattern of the two prote-
ases accounts for individual substrate preferences. Subcellular traf-
ﬁcking of proteases as well as of substrates is a well-recognised
mechanism of regulating RIP [8]. For targeting to lysosomes, mem-
brane proteins depend on distinct short motifs contained within
their cytoplasmic domains. These are able to interact with adaptor
protein complexes in the cytosol [9]. Depending on the critical
residues, canonical lysosomal targeting motifs are classiﬁed as
tyrosine- or dileucine-based signals [9].
We have analysed the molecular requirements for lysosomal/
late endosomal sorting of SPPL2a in comparison to thelsevier B.V. All rights reserved.
Fig. 1. Predicted topology and lysosomal/late endosomal localisation of SPPL2a. (A) The topology of murine SPPL2a as predicted by TMHMM (http://www.expasy.org).
Numbers indicate the limiting extra-membraneous residues. Positions of putative tyrosine-based lysosomal targeting motifs, N-glycosylation sites and the catalytically
critical YD and GFGD motifs are marked. (B) HeLa cells were transiently transfected with SPPL2a-Myc. Overexpressed SPPL2a was visualised using anti-Myc (upper and lower
panel) or a novel antibody against the native SPPL2a protein (lower panel). In the upper panel lysosomes/late endosomes were revealed with an antibody against LAMP2. (C)
In MEF cells endogenous SPPL2a was detected with the novel antibody validated above (B, lower panel). Co-staining with antibodies against LAMP2 and BMP (lysosomes/late
endosomes) and the transferrin receptor (TfR, early and recycling endosomes) was performed. Scale bars: 10 lm.
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based on SPPL2a/b chimaeric constructs and mutagenesis of puta-
tive targeting motifs within SPPL2a, we could demonstrate that a
single tyrosine-based sorting motif within SPPL2a is sufﬁcient to
mediate transport of this protease to lysosomes.2. Materials and methods
2.1. Antibodies
Antibodies against the myc epitope were purchased from Cell
signaling (Danvers, MA, USA) and Santa Cruz (Santa Cruz, CA,
USA). A monoclonal antibody against h-LAMP2 (2D5) has beendescribed previously [10] and anti-BMP (bis(monoacylglycero)
phosphate, 6C4) was kindly provided by Jean Gruenberg, Univer-
sity of Geneva. Anti-transferrin receptor (Clone H68.4) and
anti-glyceraldehyde-3-phosphate-dehygrogenase (GAPDH) were
obtained from Invitrogen (Carlsbad, CA, USA) and Sigma–Aldrich
(Taufkirchen, Germany). Secondary antibodies were purchased
from Molecular probes (Eugene, OR, USA) and Dianova (Hamburg,
Germany).
An antiserum against the native SPPL2a protein was produced
by cDNA immunisation. Expression constructs were generated by
cloning the murine and human SPPL2a ORFs into the pcDNA3.1/
Hygro+ vector (Invitrogen, Carlsbad, CA) and conjugated to 1-lm
gold particles (Bio-Rad, Hercules, CA, USA). Rabbits were immun-
ised by ballistic DNA immunization with a mixture of both
Fig. 2. The carboxyterminal cytosolic domain of SPPL2a mediates lysosomal/late endosomal targeting. (A) Schematic representation of SPPL2a (red) and SPPL2b (blue) wild
type as well as SPPL2a/b chimaeric proteins (SPPL2a-Ctail2b, SPPL2b-Ctail2a). (B) HeLa cells were transiently transfected as indicated and the distribution of the respective
proteins was analysed by indirect immunoﬂuorescence using anti-Myc. Lysosomes/late endosomes were visualised with anti-LAMP2. Scale bars: 10 lm.
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um sample was obtained 10 days after the last immunisation [11].
The complete serum was used for immunocytochemical stainings
at a 1:100 dilution. For Western blot detection of murine SPPL2a,
an antiserum was generated against a synthetic peptide (residues
77–94, CHLSDIPPDGIRNKAVVVH). After afﬁnity puriﬁcation
against the immobilised peptide the antibody was employed at a
ﬁnal concentration of 6 lg/ml for Western blotting.
2.2. Cloning of SPPL expression constructs, SPPL2a mutants and
SPPL2a/b chimaera
The ORFs of murine SPPL2a and SPPL2b were fused to a Myc tag
at their 30 end by PCR and subcloned into pcDNA3.1/Hygro+.Mutations of putative targeting signals within the murine SPPL2a
ORF (Fig. 3A) were introduced by overlap-extension PCR. For the
generation of the chimaeric constructs (Figs. 2A and 4A), fragments
corresponding to amino acid residues 1–485 of murine SPPL2a and
residues 1–484 of murine SPPL2b were fused to PCR products
corresponding to amino acids 485–578 of SPPL2b and 486–523 of
SPPL2a, respectively. All chimaeric constructs contained a 30-Myc
tag.
2.3. Cell culture and transfection
Murine embryonic ﬁbroblasts (MEF) and HeLa cells were main-
tained in DMEM (Dulbecco’s modiﬁed Eagle’s medium; PAA, Cölbe,
Germany) supplemented with 10% (v/v) FBS (fetal bovine serum;
Fig. 3. A single tyrosine-based targeting motif is critical for lysosomal/late endosomal targeting of SPPL2a. (A) Scheme of SPPL2a illustrating positions of the two tyrosine
residues that were mutated. (B) Hela cells were transiently transfected with wild type or mutant SPPL2a as indicated and the overexpressed protein detected with anti-Myc.
Lysosomes/late endosomes were visualised in parallel by co-staining against LAMP2. Scale bars: 10 lm. (C) Surface biotinylation of HeLa cells transiently transfected with
empty vector or SPPL2a, wild-type or mutant, as indicated. Aliquots of total lysates (430 lg protein) were used for pulldown with streptavidin agarose. After washing,
biotinylated proteins (Bound) were recovered in 100 ll SDS–PAGE sample buffer. For Western blotting, 35 ll of the eluted biotinylated proteins (Bound) and total lysate
aliquots (15 lg protein) were subjected to SDS–PAGE meaning, that, in relative terms, the analysed sample of streptavidin-bound proteins was derived from a 10-fold higher
amount of material. Signals shown for ‘‘Bound’’ and ‘‘Total’’ samples were derived from the same blotting membrane and exposure. Membranes were probed with antibodies
detecting SPPL2a, the transferrin receptor (TFR, positive control) or the cytosolic protein GAPDH as control for the speciﬁcity of the biotinylation and equal protein loading,
respectively.
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(PAA). Cells were seeded 24 h prior to transfection and transfected
with Turbofect (Fermentas, St. Leon-Rot, Germany) as described
previously [12].
2.4. Indirect immunoﬂuorescence
Immunocytochemical stainings were performed as described
previously [12]. Cells were ﬁxed 48 h after transfection. Photo-
graphs of optical sections were acquired with an Olympus
FV1000 confocal laser scanning microscope.
2.5. Surface biotinylation and streptavidin pulldown of biotinylated
proteins
Cell surface proteins were labelled 48 h after transfection with
the membrane impermeable, cleavable reagent sulfo-NHS-SS-bio-
tin [sulfosuccinimidyl-2-(biotinamido)ethyl-1,3-dithiopropionate]
(Thermo Scientiﬁc, Waltham, MA, USA) as described before [13].
Cells were harvested, lysates prepared as described [12] and pro-
tein concentration determined with a BCA protein assay kit
(bicinchoninic acid, Thermo scientiﬁc). Aliquots of lysates
(430 lg protein) were subjected to pulldown with 50 ll ofhigh-capacity streptavidin agarose resin (Thermo Scientiﬁc) [13].
Biotinylated proteins were eluted from the beads in 100 ll reduc-
ing SDS/PAGE sample buffer. For Western blot analysis [12], 35 ll
of the eluate were subjected to SDS–PAGE [14]. Aliquots from total
cell lysates (15 lg of protein) were analysed in parallel. Bands were
quantiﬁed by densitometry and the percentage of surface-localised
SPPL2a was calculated (mean of 2 independent experiments).3. Results
3.1. SPPL2a is a lysosomal/late endosomal membrane protein
We could show that overexpressed myc-tagged murine SPPL2a
in HeLa cells is present in lysosomes/late endosomes as revealed by
colocalisation with the lysosomal/late endosomal membrane pro-
tein LAMP2 (Fig. 1B, upper panel). A newly generated antibody
against native SPPL2a also recognised the overexpressed protein
in HeLa cells (Fig. 1B, lower panel). In murine embryonic ﬁbro-
blasts, this antibody was able to visualise endogenous SPPL2a
which colocalised with LAMP2 as well as the lysosomal/late endo-
somal lipid BMP (Fig. 1C). No colocalisation with early and recy-
cling endosomes (transferrin receptor) was observed (Fig. 1C).
Fig. 4. Y498 is the critical lysosomal/late endosomal sorting determinant in the cytosolic tail of SPPL2a. (A) Scheme of SPPL2b-Ctail2a chimaeric proteins including introduced
mutations. (B) HeLa cells transiently expressing SPPL2b wild type or SPPL2b-Ctail2a chimaeric proteins were analysed by indirect immunoﬂuorescence utilising anti-Myc. For
co-localisation analysis, co-staining with anti-LAMP2 was performed. Scale bars: 10 lm.
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lysosomal/late endosomal membranes. In contrast, overexpressed
SPPL2b was detected mainly at the plasma membrane (Fig. 2B).
The currently assumed topology of SPPL2a is characterised by a
luminal glycosylated N-terminal domain, nine transmembrane
segments and a short C-terminal cytoplasmic tail (Fig. 1A). Withinthe 38 residues comprising C-terminal domain of SPPL2a two mo-
tifs matching the consensus sequences of established tyrosine-
based lysosomal/endosomal targeting signals are present
(Fig. 1A): YQVM (residues 498–501) and YSTN (residues 506–
509). In SPPL2b no lysosomal targeting sequence was detected
(not shown).
Fig. 5. Multispecies alignment of the cytosolic C-terminal domain of SPPL2a. The putative sorting motifs around Y498 and Y506 are shown in red in the murine sequence and
marked by dashed boxes.
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transport
The differential localisation of both proteases prompted us to
analyse the relevance of the C-terminal domain of SPPL2a for lyso-
somal targeting by generating chimaeric proteins (Fig. 2A).
Replacement of the cytosolic domain of SPPL2a by that of SPPL2b
in the SPPL2a-Ctail2b chimaera resulted in a loss of lysosomal/late
endosomal targeting and delivery of the protein to the plasma
membrane in HeLa cells (Fig. 2B). On the contrary, the C-terminal
tail of SPPL2a was able to redirect SPPL2b from the cell surface to
intracellular compartments, mostly representing lysosomes/late
endosomes (Fig. 2B). These results show that the cytosolic tail of
SPPL2a is necessary and sufﬁcient for inducing lysosomal targeting.
3.3. The proximal tyrosine motif in the cytosolic tail of SPPL2a is
required for lysosomal sorting
We investigated a possible contribution of the two putative
tyrosine-based sorting motifs at Y498 and Y506 by site-directed
mutagenesis (Fig. 3A) and overexpression of the mutants in HeLa
cells (Fig. 3B). Mutation of the proximal tyrosine residue (Y498A)
impaired lysosomal/late endosomal targeting of SPPL2a and signif-
icant amounts of the mutant protein were detected at the plasma
membrane. In contrast, mutation of the distal motif (Y506A) had
no inﬂuence on the localisation of SPPL2a. Like the single Y498A
mutant, a double mutant of both motifs (YY498/506AA) was ob-
served at the plasma membrane to a predominant degree (Fig. 3B).
In an alternative approach, the surface expression of wild type
SPPL2a and the tyrosine mutants was analysed biochemically by
surface biotinylation of transfected HeLa cells with a membrane
impermeable reagent (Fig. 3C). Interestingly, signiﬁcant, but minor
amounts of wild type SPPL2a were recovered in the ‘‘Bound’’
fraction indicating plasma membrane localization of the overex-
pressed protein which had not been detected by immunoﬂuores-
cence. However, the level of surface expression (% of total
protein) of the Y498A (44%) and the YY498/506AA double mutant
(32%) was considerably higher than that of wild-type SPPL2a (17%)
and the Y506A mutant (16%).
These results argue for a single functional lysosomal sorting
motif in the cytosolic tail of SPPL2a at Y498. As a ﬁnal proof, we
went back to the system of the SPPL2a/b chimaera (Figs. 2 and 4)
and introduced the mentioned tyrosine mutations in the SPPL2b-
Ctail2a chimaera (Fig. 4A) which was delivered to a signiﬁcant de-
gree to lysosomes/late endosomes (Fig. 4). Similar to wild type
SPPL2a, introduction of the Y498A mutation into this chimaera
abolished lysosomal/late endosomal targeting and restored plasma
membrane localisation, which was not achieved by the Y506A mu-
tant. As expected the combination of both mutations also resulted
in localisation at the cell surface.
4. Discussion
In the present study we have revealed that lysosomal/
late endosomal sorting of murine SPPL2a depends on a singletyrosine-based motif (Y498) in its cytoplasmic tail. In a multispe-
cies alignment of SPPL2a (Fig. 5), a high degree of conservation of
this motif becomes evident. The identiﬁcation of a functional
sorting motif within the C-terminal domain provides indirect
proof that the C-terminus of SPPL2a is localised in the cytosol
since cytoplasmic exposure is a prerequisite for functionality of
such a signal.
The identiﬁed motif 498YQVM501 fully corresponds to the YXXø
consensus sequence of tyrosine-based lysosomal sorting motifs [9].
Within these types of signals, the Y residue is essential for func-
tionality and recruitment of the adaptor protein complexes AP-1
and AP-2 [9]. Ø represents an amino acid with a bulky hydrophobic
side chain, which may be V, L, I, F or M [9]. A frequent feature of
many functional tyrosine-based sorting motifs is a glycine residue
directly preceding the tyrosine which was shown to modulate the
strength of the motif [9]. Such a glycine residue is apparently miss-
ing in most of the SPPL2a sequences (Fig. 5), only SPPL2a in Canis
lupus exhibits one. Commonly, lysosomal YXXø signals are local-
ised within six to nine residues to the adjacent transmembrane
segment. In the case of murine SPPL2a, twelve amino acids sepa-
rate the tyrosine Y498 from the last transmembrane segment,
which results in a slightly wider distance to the membrane. In con-
trast to SPPL2a, several multispanning lysosomal membrane pro-
teins, e.g. CLN3, mucolipin-1, LAPTM4a and TMEM192, exhibit
multiple targeting motifs, that are often able to compensate for
each other [13,15].
The observed degree of surface localisation for wild type SPPL2a
(16%) is considerably higher than that reported for the lysosomal
protein LAMP1 (2–3%) [16]. However, in the current set-up it can-
not be excluded that overexpression has led to a saturation of the
intracellular targeting machinery. In addition to direct trafﬁcking
routes, lysosomal membrane proteins, as exempliﬁed by LAP (lyso-
somal acid phosphatase), can also follow an indirect sorting path-
way via the plasma membrane [15]. Potentially, SPPL2a also
utilises this pathway resulting in a transient association of SPPL2a
with the plasma membrane. However, it is also conceivable that a
small pool of SPPL2a is constitutively present at the cell surface.
Further studies will be needed to clarify these issues, especially
for the endogenous protein.
Functional data on SPPL2a and SPPL2b are very limited since
only three substrates have been identiﬁed to date: TNF-a [3],
Bri2 [4] and FasL [5]. Based on the widespread tissue expression
of SPPL2a [6] it may be speculated that additional substrates re-
main to be identiﬁed or that SPPL2a fulﬁls a more generalised
function in the lysosomal system. It has been reasoned that SPPL
proteases – presumably in collaboration with the c-secretase com-
plex – may provide a system for disposing of membrane stubs aris-
ing from limited proteolytic cleavage events of transmembrane
precursors and that these proteases in general contribute to the
degradation of integral membrane proteins [1,2]. It can be antici-
pated that the identiﬁcation of the lysosomal sorting determinants
of SPPL2a achieved in this study will help to dissect the intercon-
nections between function of the protease and its substrates on
one hand and their subcellular localisation and trafﬁcking on the
other.
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